Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
A single-institution case series of 13 biopsy-proven hydroxychloroquine cardiomyopathy patients documented variable outcomes after drug cessation, ranging from full functional recovery to progression requiring advanced heart failure therapies.
Cardiology May 19th 2026
Conexiant
The American Academy of Ophthalmology updated hydroxychloroquine retinopathy screening recommendations, emphasizing dose limits, OCT and FAF as primary screening modalities, and risk stratification by renal status and concurrent tamoxifen use.
Ophthalmology May 18th 2026
Consultant360
A 55-year-old man with bilateral hand arthritis, ruddy complexion, and elevated transferrin saturation presents a diagnostic reasoning challenge with implications for screening, surveillance, and family testing.
Family Medicine/General Practice May 8th 2026
Medical Professionals Reference (MPR)
A GLP-1 receptor agonist delivered directly into the knee joint received FDA Fast Track designation for osteoarthritis with synovitis, with phase 2a data not expected until 2027.
Family Medicine/General Practice May 6th 2026
Dermatology Advisor
TNF-alpha inhibitor exposure was associated with adjusted hazard ratios of 1.99 for basal cell carcinoma, 1.69 for squamous cell carcinoma, and 1.54 for melanoma in a 56,209-patient retrospective cohort.
Dermatology April 28th 2026
News Medical
Preclinical findings point to a potential role for extracellular vesicles in cartilage repair, offering insight into future directions for osteoarthritis research.
Ambulatory Care Nursing April 16th 2026